VSEE HEALTH INC Warrant 04/2 (VSEEW): Financials
Trailing 12 months ended June 30, 2026
Income statement, cash flow and balance sheet figures for VSEE HEALTH INC Warrant 04/2 (VSEEW), read directly from the XBRL data the company files with the SEC. Over the trailing twelve months the company reported $12.6M of revenue, up 10.1% year over year. Net loss was $12.5M, or $-0.44 per diluted share. Free cash flow was -$6.4M. Gross margin stood at 42.1%.
6 fiscal years of history are available, back to 2022.
Frequently asked questions
How much revenue does VSEEW make?
VSEE HEALTH INC Warrant 04/2 reported $12.6M of revenue over the trailing twelve months, for the period ended June 30, 2026. That is up 10.1% from the same period a year earlier.
Is VSEEW profitable?
VSEE HEALTH INC Warrant 04/2 was unprofitable over the trailing twelve months, with a net loss of $12.5M.
Where does this financial data come from?
Every figure on this page is read from the company's own SEC 10-Q and 10-K filings. Nothing is estimated by a third party. Quarterly figures a company does not file separately (most commonly the fourth quarter) are derived by subtracting the reported year-to-date quarters from the full fiscal year, and are labelled as derived.
What is the difference between quarterly, annual and TTM?
Quarterly shows each three-month fiscal period on its own. Annual shows the full fiscal year as filed in the 10-K. TTM (trailing twelve months) sums the last four reported quarters, which is the most current annualised view between 10-K filings.